Global RNAi Drugs Production, Demand and Key Producers, 2022-2028
It refers to the highly conservative, double stranded RNA induced, highly specific degradation of homologous mRNA in the evolutionary process
This report studies the global RNAi Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNAi Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNAi Drugs that contribute to its increasing demand across many markets.
The global RNAi Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global RNAi Drugs total production and demand, 2017-2028, (K Units)
Global RNAi Drugs total production value, 2017-2028, (USD Million)
Global RNAi Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global RNAi Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: RNAi Drugs domestic production, consumption, key domestic manufacturers and share
Global RNAi Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global RNAi Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global RNAi Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global RNAi Drugs market based on the following parameters – headquarters, production locations, products portfolio, RNAi Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNAi Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global RNAi Drugs Market, By Region:
1. How big is the global RNAi Drugs market?
2. What is the demand of the global RNAi Drugs market?
3. What is the year over year growth of the global RNAi Drugs market?
4. What is the production and production value of the global RNAi Drugs market?
5. Who are the key producers in the global RNAi Drugs market?
6. What are the growth factors driving the market demand?
This report studies the global RNAi Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for RNAi Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of RNAi Drugs that contribute to its increasing demand across many markets.
The global RNAi Drugs market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global RNAi Drugs total production and demand, 2017-2028, (K Units)
Global RNAi Drugs total production value, 2017-2028, (USD Million)
Global RNAi Drugs production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global RNAi Drugs consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: RNAi Drugs domestic production, consumption, key domestic manufacturers and share
Global RNAi Drugs production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global RNAi Drugs production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global RNAi Drugs production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global RNAi Drugs market based on the following parameters – headquarters, production locations, products portfolio, RNAi Drugs revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World RNAi Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global RNAi Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- siRNA
- miRNA
- saRNA
- Other
- Hospital
- Clinic
- Other
- Alnylam
- Novo Nordisk
- Eli Lilly
- Alexion
- Novartis
- Roche
1. How big is the global RNAi Drugs market?
2. What is the demand of the global RNAi Drugs market?
3. What is the year over year growth of the global RNAi Drugs market?
4. What is the production and production value of the global RNAi Drugs market?
5. Who are the key producers in the global RNAi Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 RNAi Drugs Introduction
1.2 World RNAi Drugs Supply & Forecast
1.2.1 World RNAi Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World RNAi Drugs Production (2017-2028)
1.2.3 World RNAi Drugs Pricing Trends (2017-2028)
1.3 World RNAi Drugs Production by Region
1.3.1 World RNAi Drugs Production Value by Region (2017-2028)
1.3.2 World RNAi Drugs Production by Region (2017-2028)
1.3.3 World RNAi Drugs Average Price by Region (2017-2028)
1.3.4 North America RNAi Drugs Production (2017-2028)
1.3.5 Europe RNAi Drugs Production (2017-2028)
1.3.6 China RNAi Drugs Production (2017-2028)
1.3.7 Japan RNAi Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNAi Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 RNAi Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World RNAi Drugs Demand (2017-2028)
2.2 World RNAi Drugs Consumption by Region
2.2.1 World RNAi Drugs Consumption by Region (2017-2022)
2.2.2 World RNAi Drugs Consumption Forecast by Region (2023-2028)
2.3 United States RNAi Drugs Consumption (2017-2028)
2.4 China RNAi Drugs Consumption (2017-2028)
2.5 Europe RNAi Drugs Consumption (2017-2028)
2.6 Japan RNAi Drugs Consumption (2017-2028)
2.7 South Korea RNAi Drugs Consumption (2017-2028)
2.8 ASEAN RNAi Drugs Consumption (2017-2028)
2.9 India RNAi Drugs Consumption (2017-2028)
3 WORLD RNAI DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World RNAi Drugs Production Value by Manufacturer (2017-2022)
3.2 World RNAi Drugs Production by Manufacturer (2017-2022)
3.3 World RNAi Drugs Average Price by Manufacturer (2017-2022)
3.4 RNAi Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global RNAi Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for RNAi Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for RNAi Drugs in 2021
3.6 RNAi Drugs Market: Overall Company Footprint Analysis
3.6.1 RNAi Drugs Market: Region Footprint
3.6.2 RNAi Drugs Market: Company Product Type Footprint
3.6.3 RNAi Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: RNAi Drugs Production Value Comparison
4.1.1 United States VS China: RNAi Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: RNAi Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: RNAi Drugs Production Comparison
4.2.1 United States VS China: RNAi Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: RNAi Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: RNAi Drugs Consumption Comparison
4.3.1 United States VS China: RNAi Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: RNAi Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States RNAi Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of RNAi Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States RNAi Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China RNAi Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of RNAi Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China RNAi Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World RNAi Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of RNAi Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World RNAi Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World RNAi Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 siRNA
5.2.2 miRNA
5.2.3 saRNA
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World RNAi Drugs Production by Type (2017-2028)
5.3.2 World RNAi Drugs Production Value by Type (2017-2028)
5.3.3 World RNAi Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World RNAi Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World RNAi Drugs Production by Application (2017-2028)
6.3.2 World RNAi Drugs Production Value by Application (2017-2028)
6.3.3 World RNAi Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Alnylam
7.1.1 Alnylam Details
7.1.2 Alnylam Major Business
7.1.3 Alnylam RNAi Drugs Product and Services
7.1.4 Alnylam RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Alnylam Recent Developments/Updates
7.1.6 Alnylam Competitive Strengths & Weaknesses
7.2 Novo Nordisk
7.2.1 Novo Nordisk Details
7.2.2 Novo Nordisk Major Business
7.2.3 Novo Nordisk RNAi Drugs Product and Services
7.2.4 Novo Nordisk RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Novo Nordisk Recent Developments/Updates
7.2.6 Novo Nordisk Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly RNAi Drugs Product and Services
7.3.4 Eli Lilly RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 Alexion
7.4.1 Alexion Details
7.4.2 Alexion Major Business
7.4.3 Alexion RNAi Drugs Product and Services
7.4.4 Alexion RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Alexion Recent Developments/Updates
7.4.6 Alexion Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis RNAi Drugs Product and Services
7.5.4 Novartis RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Roche
7.6.1 Roche Details
7.6.2 Roche Major Business
7.6.3 Roche RNAi Drugs Product and Services
7.6.4 Roche RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Roche Recent Developments/Updates
7.6.6 Roche Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of RNAi Drugs and Key Manufacturers
8.2 RNAi Drugs Manufacturing Costs
8.3 RNAi Drugs Production Process
8.4 RNAi Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for RNAi Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 RNAi Drugs Typical Distributors
9.3 RNAi Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 RNAi Drugs Introduction
1.2 World RNAi Drugs Supply & Forecast
1.2.1 World RNAi Drugs Production Value (2017 & 2021 & 2028)
1.2.2 World RNAi Drugs Production (2017-2028)
1.2.3 World RNAi Drugs Pricing Trends (2017-2028)
1.3 World RNAi Drugs Production by Region
1.3.1 World RNAi Drugs Production Value by Region (2017-2028)
1.3.2 World RNAi Drugs Production by Region (2017-2028)
1.3.3 World RNAi Drugs Average Price by Region (2017-2028)
1.3.4 North America RNAi Drugs Production (2017-2028)
1.3.5 Europe RNAi Drugs Production (2017-2028)
1.3.6 China RNAi Drugs Production (2017-2028)
1.3.7 Japan RNAi Drugs Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 RNAi Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 RNAi Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World RNAi Drugs Demand (2017-2028)
2.2 World RNAi Drugs Consumption by Region
2.2.1 World RNAi Drugs Consumption by Region (2017-2022)
2.2.2 World RNAi Drugs Consumption Forecast by Region (2023-2028)
2.3 United States RNAi Drugs Consumption (2017-2028)
2.4 China RNAi Drugs Consumption (2017-2028)
2.5 Europe RNAi Drugs Consumption (2017-2028)
2.6 Japan RNAi Drugs Consumption (2017-2028)
2.7 South Korea RNAi Drugs Consumption (2017-2028)
2.8 ASEAN RNAi Drugs Consumption (2017-2028)
2.9 India RNAi Drugs Consumption (2017-2028)
3 WORLD RNAI DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World RNAi Drugs Production Value by Manufacturer (2017-2022)
3.2 World RNAi Drugs Production by Manufacturer (2017-2022)
3.3 World RNAi Drugs Average Price by Manufacturer (2017-2022)
3.4 RNAi Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global RNAi Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for RNAi Drugs in 2021
3.5.3 Global Concentration Ratios (CR8) for RNAi Drugs in 2021
3.6 RNAi Drugs Market: Overall Company Footprint Analysis
3.6.1 RNAi Drugs Market: Region Footprint
3.6.2 RNAi Drugs Market: Company Product Type Footprint
3.6.3 RNAi Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: RNAi Drugs Production Value Comparison
4.1.1 United States VS China: RNAi Drugs Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: RNAi Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: RNAi Drugs Production Comparison
4.2.1 United States VS China: RNAi Drugs Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: RNAi Drugs Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: RNAi Drugs Consumption Comparison
4.3.1 United States VS China: RNAi Drugs Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: RNAi Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States RNAi Drugs Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of RNAi Drugs in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States RNAi Drugs Production by Domestic Manufacturer, (2017-2022)
4.5 China RNAi Drugs Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of RNAi Drugs in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China RNAi Drugs Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World RNAi Drugs Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of RNAi Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World RNAi Drugs Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World RNAi Drugs Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 siRNA
5.2.2 miRNA
5.2.3 saRNA
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World RNAi Drugs Production by Type (2017-2028)
5.3.2 World RNAi Drugs Production Value by Type (2017-2028)
5.3.3 World RNAi Drugs Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World RNAi Drugs Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World RNAi Drugs Production by Application (2017-2028)
6.3.2 World RNAi Drugs Production Value by Application (2017-2028)
6.3.3 World RNAi Drugs Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Alnylam
7.1.1 Alnylam Details
7.1.2 Alnylam Major Business
7.1.3 Alnylam RNAi Drugs Product and Services
7.1.4 Alnylam RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Alnylam Recent Developments/Updates
7.1.6 Alnylam Competitive Strengths & Weaknesses
7.2 Novo Nordisk
7.2.1 Novo Nordisk Details
7.2.2 Novo Nordisk Major Business
7.2.3 Novo Nordisk RNAi Drugs Product and Services
7.2.4 Novo Nordisk RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Novo Nordisk Recent Developments/Updates
7.2.6 Novo Nordisk Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly RNAi Drugs Product and Services
7.3.4 Eli Lilly RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 Alexion
7.4.1 Alexion Details
7.4.2 Alexion Major Business
7.4.3 Alexion RNAi Drugs Product and Services
7.4.4 Alexion RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Alexion Recent Developments/Updates
7.4.6 Alexion Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis RNAi Drugs Product and Services
7.5.4 Novartis RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Roche
7.6.1 Roche Details
7.6.2 Roche Major Business
7.6.3 Roche RNAi Drugs Product and Services
7.6.4 Roche RNAi Drugs Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Roche Recent Developments/Updates
7.6.6 Roche Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of RNAi Drugs and Key Manufacturers
8.2 RNAi Drugs Manufacturing Costs
8.3 RNAi Drugs Production Process
8.4 RNAi Drugs Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for RNAi Drugs Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 RNAi Drugs Typical Distributors
9.3 RNAi Drugs Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World RNAi Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World RNAi Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World RNAi Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World RNAi Drugs Production Value Market Share by Region (2017-2022)
Table 5. World RNAi Drugs Production Value Market Share by Region (2023-2028)
Table 6. World RNAi Drugs Production by Region (2017-2022) & (K Units)
Table 7. World RNAi Drugs Production by Region (2023-2028) & (K Units)
Table 8. World RNAi Drugs Production Market Share by Region (2017-2022)
Table 9. World RNAi Drugs Production Market Share by Region (2023-2028)
Table 10. World RNAi Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World RNAi Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. RNAi Drugs Major Market Trends
Table 13. World RNAi Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World RNAi Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World RNAi Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World RNAi Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key RNAi Drugs Producers in 2021
Table 18. World RNAi Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key RNAi Drugs Producers in 2021
Table 20. World RNAi Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global RNAi Drugs Company Evaluation Quadrant
Table 22. World RNAi Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and RNAi Drugs Production Site of Key Manufacturer
Table 24. RNAi Drugs Market: Company Product Type Footprint
Table 25. RNAi Drugs Market: Company Product Application Footprint
Table 26. RNAi Drugs Competitive Factors
Table 27. RNAi Drugs New Entrant and Capacity Expansion Plans
Table 28. RNAi Drugs Mergers & Acquisitions Activity
Table 29. United States VS China RNAi Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China RNAi Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China RNAi Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of RNAi Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States RNAi Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States RNAi Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States RNAi Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of RNAi Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China RNAi Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China RNAi Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China RNAi Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of RNAi Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World RNAi Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World RNAi Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World RNAi Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World RNAi Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World RNAi Drugs Production by Type (2017-2022) & (K Units)
Table 49. World RNAi Drugs Production by Type (2023-2028) & (K Units)
Table 50. World RNAi Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World RNAi Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World RNAi Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World RNAi Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World RNAi Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World RNAi Drugs Production by Application (2017-2022) & (K Units)
Table 56. World RNAi Drugs Production by Application (2023-2028) & (K Units)
Table 57. World RNAi Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World RNAi Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World RNAi Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World RNAi Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Alnylam Basic Information, Manufacturing Base and Competitors
Table 62. Alnylam Major Business
Table 63. Alnylam RNAi Drugs Product and Services
Table 64. Alnylam RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Alnylam Recent Developments/Updates
Table 66. Alnylam Competitive Strengths & Weaknesses
Table 67. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 68. Novo Nordisk Major Business
Table 69. Novo Nordisk RNAi Drugs Product and Services
Table 70. Novo Nordisk RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Novo Nordisk Recent Developments/Updates
Table 72. Novo Nordisk Competitive Strengths & Weaknesses
Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly Major Business
Table 75. Eli Lilly RNAi Drugs Product and Services
Table 76. Eli Lilly RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Eli Lilly Competitive Strengths & Weaknesses
Table 79. Alexion Basic Information, Manufacturing Base and Competitors
Table 80. Alexion Major Business
Table 81. Alexion RNAi Drugs Product and Services
Table 82. Alexion RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Alexion Recent Developments/Updates
Table 84. Alexion Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis RNAi Drugs Product and Services
Table 88. Novartis RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Novartis Recent Developments/Updates
Table 90. Roche Basic Information, Manufacturing Base and Competitors
Table 91. Roche Major Business
Table 92. Roche RNAi Drugs Product and Services
Table 93. Roche RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 94. RNAi Drugs Raw Material
Table 95. Key Manufacturers of RNAi Drugs Raw Materials
Table 96. RNAi Drugs Typical Distributors
Table 97. RNAi Drugs Typical Customers
Table 1. World RNAi Drugs Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World RNAi Drugs Production Value by Region (2017-2022) & (USD Million)
Table 3. World RNAi Drugs Production Value by Region (2023-2028) & (USD Million)
Table 4. World RNAi Drugs Production Value Market Share by Region (2017-2022)
Table 5. World RNAi Drugs Production Value Market Share by Region (2023-2028)
Table 6. World RNAi Drugs Production by Region (2017-2022) & (K Units)
Table 7. World RNAi Drugs Production by Region (2023-2028) & (K Units)
Table 8. World RNAi Drugs Production Market Share by Region (2017-2022)
Table 9. World RNAi Drugs Production Market Share by Region (2023-2028)
Table 10. World RNAi Drugs Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World RNAi Drugs Average Price by Region (2023-2028) & (US$/Unit)
Table 12. RNAi Drugs Major Market Trends
Table 13. World RNAi Drugs Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World RNAi Drugs Consumption by Region (2017-2022) & (K Units)
Table 15. World RNAi Drugs Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World RNAi Drugs Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key RNAi Drugs Producers in 2021
Table 18. World RNAi Drugs Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key RNAi Drugs Producers in 2021
Table 20. World RNAi Drugs Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global RNAi Drugs Company Evaluation Quadrant
Table 22. World RNAi Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and RNAi Drugs Production Site of Key Manufacturer
Table 24. RNAi Drugs Market: Company Product Type Footprint
Table 25. RNAi Drugs Market: Company Product Application Footprint
Table 26. RNAi Drugs Competitive Factors
Table 27. RNAi Drugs New Entrant and Capacity Expansion Plans
Table 28. RNAi Drugs Mergers & Acquisitions Activity
Table 29. United States VS China RNAi Drugs Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China RNAi Drugs Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China RNAi Drugs Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of RNAi Drugs in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States RNAi Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States RNAi Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States RNAi Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of RNAi Drugs in China, Company Headquarters and Production Place (Province, Country)
Table 38. China RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China RNAi Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China RNAi Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China RNAi Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of RNAi Drugs in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World RNAi Drugs Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World RNAi Drugs Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World RNAi Drugs Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World RNAi Drugs Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World RNAi Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World RNAi Drugs Production by Type (2017-2022) & (K Units)
Table 49. World RNAi Drugs Production by Type (2023-2028) & (K Units)
Table 50. World RNAi Drugs Production Value by Type (2017-2022) & (USD Million)
Table 51. World RNAi Drugs Production Value by Type (2023-2028) & (USD Million)
Table 52. World RNAi Drugs Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World RNAi Drugs Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World RNAi Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World RNAi Drugs Production by Application (2017-2022) & (K Units)
Table 56. World RNAi Drugs Production by Application (2023-2028) & (K Units)
Table 57. World RNAi Drugs Production Value by Application (2017-2022) & (USD Million)
Table 58. World RNAi Drugs Production Value by Application (2023-2028) & (USD Million)
Table 59. World RNAi Drugs Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World RNAi Drugs Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Alnylam Basic Information, Manufacturing Base and Competitors
Table 62. Alnylam Major Business
Table 63. Alnylam RNAi Drugs Product and Services
Table 64. Alnylam RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Alnylam Recent Developments/Updates
Table 66. Alnylam Competitive Strengths & Weaknesses
Table 67. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 68. Novo Nordisk Major Business
Table 69. Novo Nordisk RNAi Drugs Product and Services
Table 70. Novo Nordisk RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Novo Nordisk Recent Developments/Updates
Table 72. Novo Nordisk Competitive Strengths & Weaknesses
Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly Major Business
Table 75. Eli Lilly RNAi Drugs Product and Services
Table 76. Eli Lilly RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Eli Lilly Competitive Strengths & Weaknesses
Table 79. Alexion Basic Information, Manufacturing Base and Competitors
Table 80. Alexion Major Business
Table 81. Alexion RNAi Drugs Product and Services
Table 82. Alexion RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Alexion Recent Developments/Updates
Table 84. Alexion Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis RNAi Drugs Product and Services
Table 88. Novartis RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Novartis Recent Developments/Updates
Table 90. Roche Basic Information, Manufacturing Base and Competitors
Table 91. Roche Major Business
Table 92. Roche RNAi Drugs Product and Services
Table 93. Roche RNAi Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 94. RNAi Drugs Raw Material
Table 95. Key Manufacturers of RNAi Drugs Raw Materials
Table 96. RNAi Drugs Typical Distributors
Table 97. RNAi Drugs Typical Customers
LIST OF FIGURES
Figure 1. RNAi Drugs Picture
Figure 2. World RNAi Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World RNAi Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World RNAi Drugs Production (2017-2028) & (K Units)
Figure 5. World RNAi Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World RNAi Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World RNAi Drugs Production Market Share by Region (2017-2028)
Figure 8. North America RNAi Drugs Production (2017-2028) & (K Units)
Figure 9. Europe RNAi Drugs Production (2017-2028) & (K Units)
Figure 10. China RNAi Drugs Production (2017-2028) & (K Units)
Figure 11. Japan RNAi Drugs Production (2017-2028) & (K Units)
Figure 12. RNAi Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World RNAi Drugs Demand (2017-2028) & (K Units)
Figure 15. World RNAi Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 17. China RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 22. India RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of RNAi Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for RNAi Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for RNAi Drugs Markets in 2021
Figure 26. United States VS China: RNAi Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: RNAi Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: RNAi Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of RNAi Drugs in United States
Figure 30. Key Producers and Market Share of RNAi Drugs in China
Figure 31. Key Producers and Market Share of RNAi Drugs in Rest of World
Figure 32. World RNAi Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World RNAi Drugs Production Value Market Share by Type in 2021
Figure 34. siRNA
Figure 35. miRNA
Figure 36. saRNA
Figure 37. Other
Figure 38. World RNAi Drugs Production Market Share by Type (2017-2028)
Figure 39. World RNAi Drugs Production Value Market Share by Type (2017-2028)
Figure 40. World RNAi Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World RNAi Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World RNAi Drugs Production Value Market Share by Application in 2021
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Other
Figure 46. World RNAi Drugs Production Market Share by Application (2017-2028)
Figure 47. World RNAi Drugs Production Value Market Share by Application (2017-2028)
Figure 48. World RNAi Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of RNAi Drugs in 2021
Figure 50. Manufacturing Process Analysis of RNAi Drugs
Figure 51. RNAi Drugs Industrial Chain
Figure 52. Distribution Channel Breakdown for RNAi Drugs Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. RNAi Drugs Picture
Figure 2. World RNAi Drugs Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World RNAi Drugs Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World RNAi Drugs Production (2017-2028) & (K Units)
Figure 5. World RNAi Drugs Average Price (2017-2028) & (US$/Unit)
Figure 6. World RNAi Drugs Production Value Market Share by Region (2017-2028)
Figure 7. World RNAi Drugs Production Market Share by Region (2017-2028)
Figure 8. North America RNAi Drugs Production (2017-2028) & (K Units)
Figure 9. Europe RNAi Drugs Production (2017-2028) & (K Units)
Figure 10. China RNAi Drugs Production (2017-2028) & (K Units)
Figure 11. Japan RNAi Drugs Production (2017-2028) & (K Units)
Figure 12. RNAi Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World RNAi Drugs Demand (2017-2028) & (K Units)
Figure 15. World RNAi Drugs Consumption Market Share by Region (2017-2028)
Figure 16. United States RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 17. China RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 18. Europe RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 19. Japan RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 20. South Korea RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 21. ASEAN RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 22. India RNAi Drugs Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of RNAi Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for RNAi Drugs Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for RNAi Drugs Markets in 2021
Figure 26. United States VS China: RNAi Drugs Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: RNAi Drugs Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: RNAi Drugs Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of RNAi Drugs in United States
Figure 30. Key Producers and Market Share of RNAi Drugs in China
Figure 31. Key Producers and Market Share of RNAi Drugs in Rest of World
Figure 32. World RNAi Drugs Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World RNAi Drugs Production Value Market Share by Type in 2021
Figure 34. siRNA
Figure 35. miRNA
Figure 36. saRNA
Figure 37. Other
Figure 38. World RNAi Drugs Production Market Share by Type (2017-2028)
Figure 39. World RNAi Drugs Production Value Market Share by Type (2017-2028)
Figure 40. World RNAi Drugs Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World RNAi Drugs Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World RNAi Drugs Production Value Market Share by Application in 2021
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Other
Figure 46. World RNAi Drugs Production Market Share by Application (2017-2028)
Figure 47. World RNAi Drugs Production Value Market Share by Application (2017-2028)
Figure 48. World RNAi Drugs Average Price by Application (2017-2028) & (US$/Unit)
Figure 49. Manufacturing Cost Structure Analysis of RNAi Drugs in 2021
Figure 50. Manufacturing Process Analysis of RNAi Drugs
Figure 51. RNAi Drugs Industrial Chain
Figure 52. Distribution Channel Breakdown for RNAi Drugs Shipments (%): 2017-2028
Figure 53. Direct Channel Pros & Cons
Figure 54. Indirect Channel Pros & Cons
Figure 55. Methodology
Figure 56. Research Process and Data Source
